New Clinical Score for Diagnosing NASH in Obese Patients
Author Information
Author(s): Fernanda Pulzi, Raul Cisternas, Murilo Ribeiro, Christiane Ribeiro, Carlos Malheiros, João Salles
Primary Institution: Irmandade da Santa Casa de Misericórdia de São Paulo
Hypothesis
Can a clinical laboratory score effectively identify individuals with nonalcoholic steatohepatitis (NASH) among severely obese patients undergoing bariatric surgery?
Conclusion
The study found that a combination of biochemical and imaging results improved the accuracy of recognizing NASH to 84.4%.
Supporting Evidence
- 83% of patients with obesity grades II or III showed NAFLD.
- The combination of biochemical and imaging results improved accuracy to 84.4% for recognizing NASH.
- Negative final scores exclude the presence of advanced illness.
- Using this score, the severity of fatty liver infiltration can be predicted without the risks associated with hepatic biopsy.
Takeaway
Doctors created a new score to help find liver problems in very overweight patients without needing a risky liver biopsy.
Methodology
The study reviewed medical records of 66 patients who underwent gastroplasty, analyzing their chemistry profiles, abdominal ultrasounds, and liver biopsies.
Potential Biases
Potential bias due to the exclusion of patients with other liver diseases.
Limitations
The study had a small sample size and included only patients with obesity grade III.
Participant Demographics
66 patients, mean age 40.7 years, 11 males, with a mean BMI of 46.4 kg/m2.
Statistical Information
P-Value
<0.05
Confidence Interval
95%: 67% - 97.8%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website